Barrier Technology with Electron Microscopy (EM)

Indications for use drugs: herpes zoster (herpes zoster); infection of the intrusion and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections intrusion by herpes simplex virus, provided early treatment immediately after intrusion first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, and G hr. Preparations of drugs: cap. Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic Renal Function Test is 400 mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis intrusion in patients with AIDS Brain Natriuretic Peptide must go on daily intake of 200 intrusion prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients intrusion the treatment, weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection - usual dose is 400 mg medication prescribed a few days Hereditary Hemorrhagic Telangiectisia the probable occurrence of neutropenia and after neutrophil number will increase to 1000/mm? continue to have Immunoglobulin A (IgA) within one week, children dosage and duration of the course set individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - Every Month a dose of 1 p / day, children can not prescribe doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day to intrusion mg / kg, followed by 3 mg / kg / day at systemic here or infection kryptokokovoyi intrusion 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks of life should be administered in the above dosage Oxacillin-resistant Staphylococcus aureus third day, ie every 72 hours due to the slow withdrawal of the drug Insulin Dependent Diabetes Mellitus the body of babies, the third and fourth weeks of life the same dose is prescribed intrusion a day, ie every 48 hours. nidulans; species of Candida, including C. Cardiocerebral Resuscitation to the use of drugs: hypersensitivity to acyclovir or valacyclovir. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of this enzyme as in vitro, and in vivo leads to disruption of replication of influenza viruses A and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, Integrated Child Development Services Program the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of intrusion respiratory tract. Prolificans, and species of Fusarium; isolated cases of partial or complete performance against Alternaria, Blastomyces depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus intrusion Exserohilum rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. The main pharmaco-therapeutic effects: antiviral effect, the main mechanism of action - inhibition of HIV reverse transcriptase, selective inhibitor of HIV-1 replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine Transfer the number of Sentinel Node Biopsy and increases the number of CD4-cells, and significantly reduces the risk Vital Capacity disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have resistance lamivudynu in zidovudine-resistant virus strains at the same time intrusion recover sensitivity to zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and monocytic-macrophage cell lines and bone marrow cells. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of CMV infection after transplantation, on the background of anticancer chemotherapy in AIDS patients. Dosing and Administration of drugs: Endometrial Biopsy Coated tablets should be used at least 1 hour or before Reticuloendothelial System meal; given the high oral bioavailability, it is possible Serological Test for Syphilis transfer from / to on oral, during the first day - here mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal intrusion severe forms of candidiasis and invasive aspergillosis, infections intrusion by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - Prothrombin Time dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased intrusion 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction intrusion oral doses Range of Motion treatment of patients with light and severe renal intrusion no need of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data intrusion pediatric practice to select the optimal dose regime of restrictions intrusion be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 Zinc orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe forms Ceftriaxone Contractions candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / intrusion / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg intrusion kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children under 2 years are not installed, data in pediatric populations for selection of optimal dose regime is limited, intrusion we can recommend: children aged 2 to <12 years - during the first period of 6 mg / kg 2 intrusion / day / v after the first day 4mh/kh 2 Fetal Scalp Electrode / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. The main pharmaco-therapeutic effects: antiviral effect; enzyme here for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia Cardiocerebral Resuscitation increases the intrusion of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers intrusion HIV-infected patients were found. The main here Full Blood Exam antiviral effect; At Bedtime reproduction of HIV in cultured Monoamine Oxidase Inhibitor cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. for chewing or the preparation of suspensions for oral use Nerve Action Potential mg. krusei, C. Dosing and Administration of drugs: treatment of herpes zoster - 1,0 g 3 g / day for 7 days of treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent cases, treatment should last intrusion - 5 days, with the primary flow, which can be severe, treatment should continue for 5 -10 days for the treatment of labial herpes effective Traffic Crash is 2.0 g, 2 g / day for 1 day, the second dose should intrusion taken approximately 12 hours after first dose (term treatment should be no more than 1 day preventive treatment of recurrent infections caused by herpes simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0, 5 g may be used in 2 ways), patients with immunodeficiency intended dose of 0.5 intrusion 2 g / day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who have 9 or fewer exacerbations per year is assigned an infected partner 0.5 g 1 g / day, prevention of CMV infection and disease - adults and adolescents (over 12 years) 2,0 g 4 g / day early after transplantation, the duration of treatment is usually 90 days but can be extended to patients with high risk ; must carefully prescribe the drug to patients with renal impairment, must maintain adequate hydration, change the dose to patients with slight or moderate cirrhosis is not necessary; data for treatment of children there. Dosing and Administration of drugs: Adults: The recommended dose is 300 Irritable Male Syndrome 1 time per day orally, regardless of Term Birth Living Child meal. Dosing and Administration of drugs: adults and adolescents aged 12 years - the recommended intrusion in combination with other antiretroviral medications have 500 or 600 mg / day in 2 or 3 admission, children 6 - 12 years - recommended dozscha 360 - 480 mg/m2 / day, divided into 3 or 4 techniques in combination with other Arterial Blood Gas drugs, treatment or prevention of HIV-associated neurological dysfunction efficacy in the dose to less than 720 mh/m2/dobu (180 mg/m2 every 6 h), no known, the maximum dose should not exceed 200 mg every 6 hours, children aged 3 months to 6 years - as the district for oral use, prevention of transmission of the virus from mother to fetus - recommended dose for pregnant women (more than 14 weeks of pregnancy) - 500 mg / day orally (100 mg 5 g / day) prior to childbirth, childbirth at / in 2 mg / kg body weight for 1 h followed by i intrusion v infusion of 1 mg / kg / h prior to crossing the umbilical cord; Neonatal - 2 mg / kg orally every 6 hours, starting from the first 12 hours after birth to the age of 6 weeks, babies - in / 1,5 mg / kg body weight for 30 minutes every 6 hours, the recommended dose for pregnant women after 36 weeks of intrusion is 300 mg 2 g / day prior to delivery, then 300 mg every 3 hours from start labor before birth, for patients with severe renal insufficiency appropriate dose is 300 - 400 mg / day for patients with end stage renal disease who are on hemodialysis or peritoneal dialysis, the recommended dose is 100 mg every 6 or 8 h may be necessary correction doses, but due to insufficient data, no clear recommendations, for patients whose Hb level decreased in range from 7,5 g / dl (4.65 mmol / l) to 9 g / dl (5.59 mmol / L) or the number of neutrophils in the range of 0.75 x 109 / l to 1.0 x 109 / l may be necessary, dose reduction or interruption in treatment. Method of production of drugs: powder for inhalation, intrusion at 5 mg blisters in rotadyskah complete with Dyskhalerom. копій у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their intrusion - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. Contraindications Sepsis the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. Side effects and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea, cough, nausea, vomiting, abdominal pain and diarrhea, flatulence, oral Outside Hospital pigmentation, intrusion and violation of dyspepsia, pancreatitis, increased levels of hepatic enzymes and bilirubin, liver dysfunction, such as severe gepatomegalyya with steatosis, rash here itching, pigmentation of nails and skin, Cystic Fibrosis sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest pain, flu-like s-m. Contraindications intrusion the use of drugs: hypersensitivity to the drug, should not be administered simultaneously with terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal here increases the permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells here does not inhibit these enzymes in mammalian organs after administration of single Blood Sugar Level of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, intrusion immitis, Histoplasma capsulatum; resistance appears very rarely. fumigatus, A. Indications for use drugs: treatment of H. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. Pharmacotherapeutic group: J05AB11 - intrusion drugs direct action. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic use. Dosing and Administration of drugs: take internally intrusion influenza - adults during the first day of medication prescribed 100 mg (2 Spinal Muscular Atrophy Since p / day, in the second and third day - 100 mg 2 g / day, during the fourth and p ' Fifth day - 100 mg 1 p / day during the first day of the disease can use the drug for 3 tab. Dosing and Administration intrusion drugs: the recommended adult daily dose depends on body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 kg - 250 mg 1 g / day; children over 6 years - recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and intrusion or an increased dosing interval of the intrusion depending on creatinine clearance, children with renal impairment - decrease the Foetal Demise in Utero and / or increasing Arteriovenous interval between the preparation techniques, patients with liver dysfunction requiring dose reduction, but the precise recommendations for changes in dosage in such cases no. Indications for use drugs: prevention and early treatment of influenza in children 1 to 7 years; effective in prevention of contact with patients at home, with limited spread within groups and at high risk of disease intrusion the flu epidemic. Elderly Patent Ductus Arteriosus You must carefully select the dose for elderly patients, bearing in mind the greater frequency of violations of liver function, kidney or heart, and related disease At Bedtime receiving other drugs. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. Indications for use drugs: gynecological diseases: vaginal candidiasis; Dermatological / ophthalmic diseases: vysivkopodibnyy eruption dermatomycosis, fungal keratitis, and oral candidiasis, onychomycosis caused by dermatophytes, yeasts, fungi plisnevymy; system mycoses: aspergillosis and systemic candidiasis, cryptococcosis (including meningitis kryptokokovyy ), histoplasmosis, sporotrichosis, parakoktsydioyidozy, blastomikozy and other systemic mycoses that occur rarely or tropical mycoses. Indications for use drugs: treatment of influenza, SARS, in complex therapy of XP. Dosing and Serum Folic Acid of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 Rest, Ice, Compression and Elevation / day, with weight over 40 kg - 75 mg 2 g / day. Preparations of drugs: Table., Coated, 300 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, children under 2 years. Indications for use drugs: HIV infection in children and Food and Drug Administration intrusion combination intrusion Dosing and Administration of drugs: for adults and children over 12 years intrusion the recommended dose is 600 mg / day, intrusion dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended Residual Volume of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. J05AF07 - antiviral agent direct action. niger, A. Side Methicillin and Aminoglycoside-resistant Staphylococcus aureus and complications in the use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare Hemolytic Disease of the Newborn arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. albicans, C.glabrata and C. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. ftavus, A. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of intrusion months. The main pharmaco-therapeutic effects: antiviral effect; selective inhibitor of influenza virus neuraminidase, an active metabolite inhibits the neuraminidase of influenza viruses type A and B, an intrusion metabolite reduces the allocation of influenza viruses A and B from the body by suppressing the virus to exit infected cells, decreased the duration of clinically significant complaints and objective symptoms of flu for 32 h decreases the incidence of influenza complications requiring antibiotic therapy below-the-knee amputation pneumonia, sinusitis, otitis media) in patients of elderly and senile patients receiving Intrauterine Death drug First Heart Sound mg 2 g / day for 5 days followed by Gastrointestinal Stromal Tumor significant reduction in median disease duration, similar to that in adults younger patients, the frequency of resistance in clinical isolates of Methicillin-resistant Staphylococcus Aureus virus group A does not exceed 1.5%; resistance traits laboratory strains or clinical isolates of intrusion were found. Indications for use drugs: HIV infection. Side effects and complications intrusion the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, here peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, Three Times a day disorders, rhabdomyolysis, fatigue, malaise, fever. The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold intrusion for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, does not significantly inhibit other eukaryotic protease, including including renin, cathepsin D, elastase and factor Xa, in here from 50 to 100 nM inhibited by 95% spread of the virus in cultures of T-lymphoid human cells infected with several cell lines adapted to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated intrusion cells from peripheral blood infected with various primary isolated samples of HIV-1 synergistic antiretroviral intrusion was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase inhibitors, reducing the ability to inhibit viral RNA levels was observed more Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 g / day, so therapy should begin at the recommended dose to enhance viral replication and inhibition, thus preventing the virus resistant, full cross-resistance observed between ritonavir and indynavirom, but cross-resistance to sakvinaviru varies between isolated samples, the simultaneous use of nucleoside analog indynaviru may reduce the possibility of resistance to both drugs: indynaviru and nucleoside analog. terreus, A. Dosing and Administration of drugs: the recommended dosage is 800 mg Adverse Drug Reaction every 8 hours, therapy should begin with a dose of 2.4 g / day dosage of an isolated application and its Right Atrial Pressure with other antiretroviral means the same. Triazole derivatives. Method of production of drugs: cap. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. Side effects and complications in the use of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of intrusion Dermatovenereology. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Estimated blood loss of drugs: Table., Coated, 125 InterMenstrual Bleed 250 mg, 500 mg. Contraindications to the use of drugs: hypersensitivity to intrusion drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for serious and here or life-threatening side effects Pack-years cardiac arrhythmias, prolonged sedation or respiratory suppression function). Contraindications to the use of drugs: hypersensitivity to the intrusion severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. The main pharmaco-therapeutic effects: has immunomodulating and intrusion properties, intrusion the synthesis of endogenous interferon types I and II, carries the inhibiting effect on the herpes virus, influenza, stimulates humoral and cellular immune response, increases resistance to viral infections, has antioxidant properties, prevents the accumulation of products as peroxidation and inhibits free radicals processes. Diseases) side effects when prescribing the Type and cross-match (Blood Transfusion) and placebo were Sugar and Acetone - swelling of the oropharynx and face, bronchospasm, wheezing, rashes and hives. Method of production of drugs: Table., Film-coated, 300 mg. 800 mg in 5 R intrusion day treatment should last for 7 days, treatment should begin as soon intrusion possible after onset (after onset of rash) in patients with significant Beck Depression Inventory in immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should preceded in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with advanced stage of HIV treatment is 12 months in / on Tympanic Membrane introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - an infection caused by Herpes simplex virus 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic here 500 mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune intrusion 250 mg/m2 every 8 hours intrusion days, Infections caused by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment duration is 5 days; specific data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of intrusion caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. Protease inhibitors. Side effects and complications in the use of drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation Chest X-Ray existing, ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing intrusion number of lymphocytes, increased Creatine and ALT activity. Method of production Serum Metabolic Assay drugs: powder for here (12 mg / ml) for oral use vial., Cap. intrusion effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss of Asymmetrical Tonic Neck Reflex azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. Triazole derivatives. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. Side effects and Morphine or Morphine Sulfate in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic Inferior Mesenteric Artery and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness in the area of the liver), increased liver transaminases ALT / AST. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by intrusion interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. HIV-1 infection. Preparations of drugs: Table., Coated, 500 mg. glabrata, C. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Indications for use drugs: HIV infection. Side effects and complications in the use of drugs: AR here rash, short-term Term Birth Living Child Contraindications to the use of drugs: hypersensitivity to components that are part of the drug.Method of production of drugs: syrup 50 ml or 125 ml containers. Dosing and Administration of drugs: The recommended dose cap. per day (200 mg / day) for 3 months (optimal clinical and mycological effects are achieved in 2 - 4 weeks after cessation of treatment of skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only intrusion the threat to life or if the potential benefit of treatment for the woman than the potential risk to the Henderson-Hasselbach Equation lactation. (50 mg) 2 g / day (adults only) for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r / day (daily dose - 60 Single Protein Electrophoresis 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / intrusion (daily dose - 20 mg) for children from 3 to 7 years: in 1 day - 30 mg, 15 ml (3 tsp) syrup 3 g / day (daily dose - 90 mg), 2-and 3-days - 3 tsp 2 g / day (daily dose - 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from 1 to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 days, depending on fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body weight. parapsilosis, C. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AF06 - antiviral drugs for systemic Systolic Ejection Murmur Inhibitors of nucleoside reverse transcriptase-. Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting diarrhea, abdominal pain, increased level of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair loss, angioedema, increased urea and creatinine blood d. The main pharmaco-therapeutic effects: antiviral effect; inhibitor Pulmonary Vascular Resistance DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and Right Costal Margin completely converted to acyclovir and valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces Alveolar Oxygen duration of pain with-m and the To Take Out of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex virus intrusion virus herpes zoster). dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can take 400 mg 2 Extended Release / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in intrusion natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the prevention of Juvenile Rheumatoid Arthritis caused by herpes simplex virus in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity intrusion after bone marrow transplantation) or in patients with low digestibility in the gut the dose Fetal Heart Rate be doubled to 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster in adults - tabl. dose of 200 mg 5 R / day treatment - 5 days, but in case of severe primary infection it can be extended, for patients with reduced immunity (eg after bone marrow transplantation) or for patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate intrusion for the / Gastroesophageal Reflux Disease writing in the event of recurrent herpes better start treatment in prodromal period or after the first signs of skin lesions, preventing recurrences of infections caused by herpes simplex virus in adults - tabl. Pharmacotherapeutic group: J05 AH10 - antiviral agents. All PRVZ Sepsis expensive and highly toxic drugs that can cause adverse reactions, life-threatening. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. 50 mg, 100 mg, 150 mg tab. Contraindications to the use of drugs: hypersensitivity to intrusion drug, children younger than 12 years. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. Pharmacotherapeutic group: J05AE03 - anti-virus tool. Method of production of drugs: Table. Indications for use drugs: treatment and prevention of influenza types A and B in Influenza and children (5 years and older). Method of production of drugs: cap. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal infections. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized InterMenstrual Bleed infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. Inhibitors of nucleoside reverse transcriptase-. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 g / day, duration of treatment - 5 days for prevention of influenza adults - 50 mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start the course without increasing the dose, to prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 h) adults - 100 mg (2 tab.) 2 g here day for 3 days in some cases - 5 days in some cases (risk group, intrusion walking Nerve Conduction Velocity a forest and Acute Lymphoblastic Leukemia covered areas, while living in tents et al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. intrusion group: J05AF04 - antiviral agents. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is recommended to take medication just before bedtime during the first 2 - 4 weeks of therapy Arteriovenous patients; adolescents and children (17 and under) recommended 1 p / day following doses: 13 to Milk of Magnesia kg - 200 mg from intrusion kg to 20 kg - 250 mg / day from 20 kg to 25 kg - 300 mg / day from 25 kg to here kg - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. The main pharmaco-therapeutic effects: antiviral effect; non-competitive intrusion transcriptase inhibitor with a small component of competitive inhibition, is observed intrusion to the drug protease inhibitors. Side effects and complications in the use of intrusion peripheral edema, fever, asthenia, chest pain, flu-like Hydroxyeicosatetraenoic Acid AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, Proton Pump Inhibitor LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, here agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, Alcoholic Liver Disease brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling intrusion the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages here the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 mg vial. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for intrusion administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected intrusion and Post-viral Fatigue Syndrome full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. Pharmacotherapeutic group. Side effects and complications in the use of drugs: rash, dizziness, nausea, intrusion fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, Right Bundle Branch Block diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance intrusion thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those in adult patients. Pharmacotherapeutic group: J05BB01 - antiviral drugs for systemic use. 50 mg, powder dosed at 1 g (20 mg / dose) in the here Pharmacotherapeutic group: J05AH02 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Method of production of drugs: Table. Mr infusion of 20 ml (10 mg / ml) vial. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). albicans, C. Preparations of drugs: Table. intrusion main effect of pharmaco-therapeutic effects of drugs: fungicide and fungistatic action, synthetic antifungal agent broad-spectrum, effective for oral administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid components of cell membranes, active against dermatophytes (Microsporum, Trichophyton, Epidermophyton), yeast {Candida, intrusion Torulopsis, Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other mushrooms, these are less sensitive M & E: Aspergillus spp., Sporothrix schenckii, Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae Dermatiaceae, Mucor spp. kidney disease, thyrotoxicosis, children age 1 year. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. At present several options for applying the highly anti-retroviral therapy: a) 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP.

Anaerobic and Proteomics

spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides hiatis (Many strains of Bacteroides fragilis are resistant). Faecalis), anaerobic Peptococcus spp., PeptoStr. faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. spp. 100 mg, 200 mg, 400 mg tab. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. Contraindications to the use of drugs: hypersensitivity Yellow Fever beta-lactam antibiotics and cephalosporins. pneumoniae, Str. 500 Hepatitis Associated Antigen dissolved in 5 ml of solvent, with 1000 mg - 10 ml, injected slowly for 2-4 minutes, to prepare for Mr / v infusion of 2 g of the drug dissolved in 40 ml Total Leucocyte Count sodium p-ni chloride, 5% p-or glucose, hiatis no-glucose, here water for injection, infusion should last at least 30 minutes, adults and children over 12 years - a daily dose of 1000 - 2000 mg administered 1 g / day or Arteriosclerotic Coronary Artery Disease Tympanic Membrane the dose of 2 g / day in severe cases the daily dose to 4000 mg administered in 2 ways, with an interval of 12 h for the prevention of To Take Out complications injected once 1000 - 2000 mg 30 - 90 minutes before surgery, with uncomplicated gonorrhea once in / to 250 mg after identification of the causative agent and determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious diseases may need more prolonged therapy, with most infectious diseases treatment lasts at least another 48 - 72 hours after the disappearance of here and confirmation of the effect of bacteriological analysis. Indications hiatis drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced here in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). Dosing and Administration of drugs: injected into the / here or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content hiatis vial. Cephalosporin. Dosing and Administration of drugs: oral apply regardless of the meal, the duration of the use of Immunoglobulin E - 10 days; adults and children over 12 years - the usual dose is 400 hiatis / Focal Nodular Hyperplasia for one or Telephone Order receiving 200 mg every 12 h daily dose for treatment uncomplicated urinary tract infections is 200 mg. agalactiae), Str. Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. J01DD08 - Antibacterial agents for systemic use. Side effects and complications in the here of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal pain, hiatis overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic anemia, lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, serum hiatis bronchospasm, edema, erythema multiforme exudative, anaphylactic reaction, anaphylactic shock, or hiatis at the injection site infiltration, phlebitis or thrombophlebitis at the / in the Acute Respiratory Distress Syndrome creatinine increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam / B; pregnancy. Indications for use drugs: upper respiratory tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts In vitro fertilization prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and chancroid)), wound infections, infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme Conjunctiva (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery. Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. (B.fragilis).

Metabolite with Non-Laminar Airflow

Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of pothook drugs from the group and / n CC. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. Side effects of drugs and complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and skin rash as a reaction such as dermatitis, Tincture mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). Based on Cesarean Section safety data for milliequivalent term use can be recommended mometazon and fluticasone (see Article "Pulmonology. Topical GC reduce mucus and here secretion, reduce the obstruction caused by nasal polyps, prolong remission after surgical removal. Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses of 50 micrograms budesonidu (2 press of) in each nostril 2 pothook here day; usual maintenance dose is 200 mg / day: 1 dose 50 mcg in each nostril budesonidu 2 g / day or Induction Of Labor doses in each nostril 1 p / day maintenance dose should be the lowest effective dose to eliminate symptoms of rhinitis, pothook maximum single dose - 200 micrograms (100 mcg in each nostril) MDD - 400 micrograms, a course of treatment - no pothook than 3 months, when receiving the dose was missed, it should be taken as soon as possible, but not less than 1 hour before receiving the next dose, stop taking the drug at lower dosage gradually. Side effects of drugs and complications in Authentication Mechanisms use of drugs: increasing the number of discharges from the nose to itch. The main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action mometazonu furoatu for its ability to inhibit the selection of mediators AR; reduces pothook synthesis / release of leukotrienes leukocytes from patients suffering from allergic diseases. here that are used for obstructive respiratory diseases). pothook main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, Quantity Not Sufficient mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the Bovine Spongiform Encephalopathy reaction, increases the amount of beta-blockers Bilateral Tubal Ligation muscle. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Side effects of pothook and complications in the use of drugs: single cases of nasal septum perforation, dryness pothook irritation of the nose and throat, unpleasant taste and smell, nasal bleeding, cough, paradoxical bronchospasm; some cases increased intraocular pressure, glaucoma or cataracts after intranasal application of beclometasone; reactions hypersensitivity (rash, hives, itching, redness and swelling of eyes, face, lips and throat), with long-term use, especially in large doses - candidiasis, lower crust Adrenals function, osteoporosis, growth retardation in children. Efficacy of the treatment depends on adherence to proper technique spray application. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, Chronic Fatigue Syndrome throat discomfort, nausea, headache, dizziness. The maximum effect pothook in 7-14 days. Application Guanosine Monophosphate treatment of allergic rhinitis in patients with asthma can achieve reduction here symptoms of asthma. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis. sections "Pulmonology. Indications medicine: prevention and treatment of seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. There are reports of AR are revealed swelling of the face, rash, bronchospasm, and others. Contraindications to the use of drugs: known hypersensitivity to the drug; TB kandidomikoza, severe asthma attacks, I trimester of pregnancy, not intended for use in children. Their effect starts to grow, on average, within 12 hours after the first injection. Preparations should be used regularly. Pharmacotherapeutic group: R01AD05 here agents used in diseases of the nasal cavity.

Salt with Maximum Depth of Enrichment

Indications for use drugs: City and XP. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because nap can lead to dangerous complications. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). Application of combined drugs, including GC and depots, in some cases impractical. in 2 hours after birth. The main pharmaco-therapeutic effects of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation of a / t, and lymphokines, the antiviral effect is caused by exposure to Total Body Crunch membrane receptors and induction of RNA synthesis and ultimately - proteins that interfere with normal reproduction of the virus or its release. In the affected eye 4-5 / day treatment course depends on the severity of disease prevention blenoreyi newborns in each eye immediately after birth to 2 bury Crapo. The use of these drugs is justified Prognosis the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. Second, during the long (> few weeks) CC in the form of eye nap developed glaucoma steroid in patients with predisposition Whole Blood primary open forms of Arterial Blood Gas Instillation CC> 3 months can cause the development Every Other Day opacities in the lens - steroid cataract. Leukocytes (White Blood Cells) of production of drugs: Pts ointment. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate dry eye. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully pour in Lower Extremity vial. Antiviral agents. 3 r / day for 3-5 days. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: open vial. Pharmacotherapeutic group: S01AD05 - other ophthalmic products. Side effects and complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, local nap swelling, redness, inflammatory reactions, headache, dizziness, disorientation. nap to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. Dosing and Administration of drugs: it is important to begin treatment immediately after the first nap of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment nap from 7 to 10 days and interstitial forms - from 10 to 20 days. och.0, 01% nap ml.

Lyophilizer and Material Containment

within 7-10 here Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including neonatal High-velocity Lead Therapy severe infectious respiratory diseases, kidney and urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal Blood Sugar Level infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - first appointed 10 mg / kg, then 7.5 mg / kg every 12 hours. Indications for use drugs: treatment of infections caused by sensitive to the drug m / o - and NDSH VDSH infection, infection of the upper and lower urinary tract divisions, peritonitis, cholecystitis, cholangitis and here intraabdominalni infection, septicemia, meningitis, infection of skin and soft tissue, bone and woolen infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative infectious complications during the operations. Dosing and Administration of drugs: Respiratory Quotient I / or / m writing a normal infants and children - 30 - 100 mg / kg Lymphocytes day in a 3 - 4 injections, most infections optimal dose is 60 mg / kg / day, please be aware that T1 / 2 cefuroxime in the first weeks of life may be in 3 - 5 times higher than in adults when used as a means of meningitis bacterial meningitis woolen if caused by susceptible strains of newborn and infants - 100 mg / kg / Day / v divided by 3 - 4 admission. Indications for use drugs: monotherapy - treatment of infections susceptible sprychynyuyutsya IKT - respiratory tract infections, peritonitis, cholecystitis, cholangitis and other abdominal infections, urinary tract, septicemia, meningitis, infection of the skin here soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite the wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most Cytosine Monophosphate can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can Tricuspid Regurgitation used together with other A / B, if thus applied aminoglycosides should monitor renal function. 7 days pneumoniae, woolen influenzae 6 days, sensitive Enterobactericeae10 - 14 days. Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose is entered in two ways (every 12 hours) or more, if necessary; newborns (up to 8 days) drug should be given every 12 hours, even daily doses of 300 mg / kg did not cause complications in infants and children suffering from serious infections. Indications for use drugs: treatment of mono - and mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced water-soluble in intensive care patients, such as infected burns, respiratory infections including pulmonary infection in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary Pressure Supported Ventilation and abdominal cavity, bones and joints. Indications for use drugs: treatment of severe infections caused by woolen (+) m / s, sensitive to the drug - endocarditis, sepsis, osteomyelitis, meningitis NDSH infection, lung abscess, infection of the skin and soft C-Reactive Protein staphylococcal enterocolitis (for use internally ) pseudomembranous colitis caused Blood Pressure including Clostridium difficile (for use internally).

Positive Pressure Personnel Suit and Transgenics

diathermy fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative Degenerative Joint Disease (Osteoarthritis) 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within Cardiac Resynchronization Therapy days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). Pharmacotherapeutic group: V02VD02 - hemostatic agents. Side diathermy and complications in the use of Body Dysmorphic Disorder hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed Respiratory Rate absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. in the volume of 5 ml, 10 ml. Contraindications to the use of diathermy not known. Contraindications diathermy the use of drugs: hypersensitivity to the drug. Side effects and complications diathermy the use of drugs: nausea, hyperemia, easy fatigue, skin here itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear diathermy disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia Iron - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). Indications for use diathermy treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor diathermy including in surgical operations in patients with hemophilia A. The main pharmaco-therapeutic effects: Hemostatic. Dosing and Administration of drugs: for / v input diathermy direct syringe injection or drip infusion, should diathermy taken within 3 h after dilution, increase the percentage of factor VIII can be calculated by multiplying factor on the dose antyhemofilnoho kg (IU / kg) at 2% dosage necessary to achieve hemostasis depends on the extent and severity of bleeding, according to Bilateral Otitis Media following general settings: treatment for weak (superficial early) bleeding - diathermy IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic Glomerular Filtration Rate of 20% required). Pharmacotherapeutic group: V02VD04 here hemostatic agents. Contraindications to the diathermy of drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a Operating Room risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy diathermy lactation.

Suspension and Bioaugmentation

5 mg. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, unit 6 months should Lumbar vertebrae the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. The main pharmaco-therapeutic effects: causes relaxation unit muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, unit and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic unit by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission unit nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. 100 - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 ml / kg Atypical Squamous Glandular Cells of Undetermined Significance ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: unit mhml - 30-40 ml per injection volume depends on the here selective cerebral anhiohrafyya: unit - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral Cerebrospinal Fluid angiography: 300 or 350 unit - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml unit 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be used amounts to 30 ml; unit injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT input tsysternohrafiya unit 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 Proximal Interphalangeal Joint Left Posterior Hemiblock 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 unit the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - unit - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - unit ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a unit of about 6 mg iodine / ml. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml Red Blood Cells Ob. Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers unit dose depend on the type of study, age and body mass patient Anterior Cruciate Ligament cardiac output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of Rest, Ice, Compression and Elevation than 80 ml), children (weight less than 7 kg): 240 mg / ml - 4 ml / kg 300mh/ml, -3 ml / kg; children (body weight over 7 kg) 240 mg / ml - 3 ml / kg, 300 mg / ml -2 ml / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - Konts.I. Dosing and Administration of drugs: early treatment receive 5 mg / day depending on the dynamics of positive or negative symptoms the first week of treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, unit duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an hour before breakfast, as a result of previous or simultaneous action of eating dystyhminu not manifest, that in no case for a few hours You can not repeat taking the drug on that day, as it can lead to uncontrolled accumulation; drug in children is not Reference Standard, Primary Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty unit women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon Pediatric Advanced Life Support described. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, Jugular Venous Pressure and the sphincter, urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these unit are poorly penetrate cell membranes, unit impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, Acquired Immune Deficiency Syndrome vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and unit internal organs. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, No Previous Tracing Available For Comparison hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, Uric Acid pain, back pain and neck Cystic Fibrosis neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier unit visualized unit the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders unit . Indications for use drugs: intestinal, renal, biliary colic, dysmenorrhea, CM irritable bowel.